Previous Next

ARCHIVE

№1' 2008

THERAPY

International Medical Journal, Vol. 14., Iss. 1, 2008, P. 71−78.


ADVANTAGES OF COMBINATION DRUG THERAPY IN CORRECTION OF DYSLIPIDEMIA IN METABOLIC SYNDROME AND TYPE 2 DIABETES MELLITUS


Kovaliova O. N., Kravchenko N. A.

Kharkiv National Medical University, Kharkiv, Ukraine

The necessity of combined therapy with statins/fibrates for control of lipid metabolism disorders at metabolic syndrome and diabetes mellitus is shown.

Key words: metabolic syndrome, hypolipidemic therapy, statins, fibrates.


Go on Top